melosus - search results

European Union - English - EMA (European Medicines Agency)

melosus

cp-pharma handelsgesellschaft mbh - meloxicam - musculo-skeletal system - dogs; cats; guinea pigs - dogs:alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.cats:alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.alleviation of pain and inflammation in chronic musculo-skeletal disorders in cats.guinea pigs:alleviation of mild to moderate post-operative pain associated with soft tissue surgery such as male castration.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

melosus 0.5 mg/ml oral suspension for cats

cp pharma handelsgesellschaft mbh - meloxicam - oral suspension - anti inflammatory nsaid - cats

United Kingdom - English - VMD (Veterinary Medicines Directorate)

melosus 1.5 mg/ml oral suspension for dogs

cp pharma handelsgesellschaft mbh - meloxicam - oral drops, suspension - anti inflammatory nsaid - dogs

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma open use permit 14650- paramite selective miticide/ melons/ two-spotted mites

apvma permit - etoxazole(110g/l) - group 10b insecticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma limited use permit 13170- dimethoate/ melons- post harvest/ fruit fly

apvma permit - dimethoate(400g/l) - group 1b insecticide

European Union - English - EMA (European Medicines Agency)

benlysta

glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, systemic - immunosuppressants - benlysta is indicated as add-on therapy in patients aged 5 years and older with active, autoantibody positive systemic lupus erythematosus (sle) with a high degree of disease activity (e.g., positive anti dsdna and low complement) despite standard therapy.benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.

European Union - English - EMA (European Medicines Agency)

saphnelo

astrazeneca ab - anifrolumab - lupus erythematosus, systemic - immunosuppressants - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.,

Australia - English - Department of Health (Therapeutic Goods Administration)

surgical/medical respirator, single-use

celsus international pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

airway protection face mask

celsus international pty ltd - 18094 - airway protection face mask - intended to be used over the nose and mouth to provide respiratory protection and act as a protective barrier from airborne particles. it is not intended to be reprocessed after each use.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

panoctine liquid fungicide